Med Dosage 13-24

• Adult: 5–15 mg IV
• Pediatric - 0.5 mg/kg rectally

• 0.25 mg/kg over 2 min
• Repeat 0.35 mg/kg if no response in 15 min
• Maximum single dose: 20-25 mg.
• Maintenance infusion of 5–15 mg/hr

• Adult: 25–50 mg IV, IM, or PO
• Pediatric: 1 mg/kg up to adult dose

• 2-20 mcg/kg/minute IV infusion:
• Improve cardiac output (beta): 5-10 mcg/kg/minute
• Increase peripheral vascular resistance (alpha): 10-20 mcg/kg/minute

• 14-60 y/o: 2.5-5 mg IM or IV (may be combined with 2 mg midazolam insame syringe for increased sedation), may be repeated onceas needed
• Over 60 y/o: 2.5 mg (with or without midazolam). Not recommended asfirst line anti-N&V med because of “black box” warning

• Cardiac arrest: 1.0 mg/3-5 min IV (1:10,000), 2.0 mg/3-5 min ET
• Bradycardia: 2-10 mcg/min
• Anaphylaxis: 0.3-0.5 mg IM every 5-15 min (1:1000), 0.3-0.5 mg given3-5 min slow IV (1:10,000)
• Croup: 0.05 ml/kg via nebulizer (2.25% racemic epinephrine added to 3ml saline)

0.3 mg/kg IV

2 mcg/kg IV or IM, usually up to 100 mcg

20-80 mg IV/IM (Varies greatly by protocol, generally don’t administeran initial dose of more than 20 mg to a patient who does not takefurosemide)

• Antihypoglycemic: 1 mg IM, large doses
• Beta blocker overdose: (3–10 mg IV).

2-5 mg IM (may be combined midazolam)

5-10 units (Regular) IV given with 25 g D50